M. T. Khoa

发表

Stereotactic radiosurgery for newly diagnosed brain metastases

D. Rades, S. Schild, O. Blanck, 2014, Strahlentherapie und Onkologie.

The number of involved extracranial organs: A new predictor of survival in breast cancer patients with brain metastasis

D. Rades, S. Schild, V. Nagy, 2013, Clinical Neurology and Neurosurgery.

A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone.

D. Rades, S. Schild, T. Veninga, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rotating Gamma System Irradiation: A Promising Treatment for Low-grade Brainstem Gliomas.

D. Rades, M. T. Khoa, Pham Cam Phuong, 2017, In vivo.

Epidemiological Characteristics of Women Participat-ing in Breast Cancer Screening by Bach Mai Hospital

M. T. Khoa, Pham Cam Phuong, Nguyen Thi Hoa Mai, 2019, Biomedical Journal of Scientific & Technical Research.

Evaluation of Five Survival Scores in a Cohort of Elderly Patients With Cerebral Metastasis from Non-small Cell Lung Cancer

D. Rades, S. Schild, S. Janssen, 2020, AntiCancer Research.

Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder.

D. Rades, S. Schild, S. Janssen, 2018, In vivo.

Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases.

N. Gebauer, D. Rades, S. Schild, 2018, Anticancer research.

Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases.

D. Rades, S. Schild, O. Blanck, 2018, In vivo.

Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers.

D. Rades, S. Schild, T. Veninga, 2016, Anticancer research.

Out-of-pocket payments for complementary medicine following cancer and the effect on financial outcomes in middle-income countries in southeast Asia: a prospective cohort study.

S. Sangrajrang, C. Yip, S. Jan, 2022, The Lancet. Global health.

A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy.

D. Rades, S. Schild, M. T. Khoa, 2017, In vivo.

Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer.

D. Rades, S. Schild, O. Blanck, 2015, Anticancer research.

Predicting Survival After Irradiation for Brain Metastases from Head and Neck Cancer.

D. Rades, V. Rudat, S. Hakim, 2015, In vivo.

Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer.

D. Rades, S. Janssen, Markus Dahlke, 2015, Anticancer research.

Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.

D. Rades, S. Schild, S. Huttenlocher, 2015, Anticancer research.

Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary

D. Rades, S. Schild, S. Janssen, 2020, AntiCancer Research.

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

S. Thongprasert, Chun-Ming Tsai, Pan‐Chyr Yang, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.

D. Rades, S. Schild, V. Nagy, 2014, Anticancer research.

Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients.

D. Rades, S. Schild, S. Huttenlocher, 2015, Oncology letters.

Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma.

N. Gebauer, D. Rades, S. Schild, 2015, Anticancer research.

Impacts of Novel Vietnamese Government Regulations on Radiological PhD and Professorship Candidates: an Initial Report

N. M. Duc, M. T. Khoa, P. M. Thong, 2020, Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH.

A simple survival score for patients with brain metastases from breast cancer

D. Rades, S. Schild, V. Nagy, 2013, Strahlentherapie und Onkologie.

A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases

D. Rades, S. Schild, T. Veninga, 2017, Radiation Oncology.

Molecular epidemiological prospective study of EGFR mutations from Asian patients (pts) with advanced lung adenocarcinoma (PIONEER).

S. Thongprasert, Chun-Ming Tsai, Pan‐Chyr Yang, 2012 .

Brain metastasis from non-small cell lung cancer (NSCLC)

D. Rades, S. Schild, V. Nagy, 2013, Strahlentherapie und Onkologie.

A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases

D. Rades, S. Schild, T. Veninga, 2017, Radiation oncology.

A new survival score for patients with brain metastases from non-small cell lung cancer

D. Rades, S. Schild, V. Nagy, 2013, Strahlentherapie und Onkologie (Print).

Radiosurgery with a Rotating Gamma System: A Very Effective Treatment for Symptomatic Cerebral Cavernomas.

Nguyen Duc Luan, D. Rades, S. Schild, 2017, Anticancer research.

Brain metastasis

D. Rades, S. Schild, V. Nagy, 2013, Strahlentherapie und Onkologie.

A New Tool Predicting Survival After Radiosurgery Alone for One or Two Cerebral Metastases from Lung Cancer

D. Rades, S. Schild, S. Huttenlocher, 2015, Lung.

Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients.

D. Rades, S. Schild, A. Bajrovic, 2015, Anticancer Research.

Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.

D. Rades, S. Schild, S. Huttenlocher, 2014, Anticancer research.